Obregón GG, Díaz LMLV, Martínez CJ

Language: Spanish
References: 10
Page: 154-160
PDF size: 394.86 Kb.

ABSTRACT

Background: The sudden hearing loss must be considered like a medical urgency within the field of the otolaryngology. Factors exist that influence the effectiveness of the treatment, making difficult their study, like the severity of hearing loss, type of audiometric curve, presence of vertigo, time of beginning of treatment, age and personal antecedents. Nevertheless a high rank of spontaneous resolution has been documented.
Objective: To analyze the effectiveness of the treatment administered to all the cases of sudden hearing loss of January to September of 2003 at National Medical Center, IMSS, of the city of Leon, Guanajuato.
Material and methods: We made a retrospective and descriptive study of 13 patients with diagnosis of sudden hearing loss. We divided the patients in three groups in agreement to the type of treatment: combined (prednisona, pentoxifilina, acyclovir), six patients (46.2%); treatment with vasodilator (cinarizina), five patients (38.5%); without treatment two patients (15.3%).
Results: In the first group an improvement of 66% was observed, 40% in the second and without improvement in third.
Conclusion: We concluded that the combined treatment group presented better results than the treatment only with vasodilator. The patients without treatment were not observed any type of improvement.

REFERENCES

1. Hughes G, Freedman M, Haberkamp T, Guay MC. Hipoacusia neurosensorial súbita. Actualización en Otología y Neurootología. Clínic Otorrinolaringológ N A 1996;3(Parte II):403-16.

2. Chandrasekhar SS. Intratympanic dexamethasona for suden sensorineural hearing loss. Clinical and Laboratory Evaluation. Otology and Neurotology 2001;22:18-23.

3. George T. Hashisaki. Sudden sensory hearing loss. Head and Neck Surgery. Lippincott-Raven 2nd ed. 1998; Vol II:2193-8.

4. Sano H, Okamoto M, Shitara T, Hirayama M. Hearing recovery and its process from the time of onset in sudden deafness. Acta Otolaryngol Suppl 1996;524:36-8.

5. Kronenberg J, Almagor M, Bendet E, Kushnir D. Vasoactive therapy versus placebo in the treatment of suden hearing loss: a double-blind clinical study. Laryngoscope 1992;102:65-68.

6. Fernández M, Martínez F, Martín R. Hipoacusia súbita. Experiencia clínica con 54 pacientes. An Orl Mex 1994;39:143-7.

7. Eisenman D, Art HA. Effectiveness of treatment for sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. 2000;126:1161-4.

8. Kallinen J, Laippala P, Laurikainene E, Grenman R. Suden deafness: A comparison of anticoagulant therapy and carbogen inhalation therapy. Ann Otol Rhinol Laryngol 1997;106: 22-26.

9. Lefebvre PP, Staecker H. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol 2002;122:698-702.

10. Alexiou C, Arnold W, Fauser C, Schratzenstaller B, et al. Sudden sensorineural hearing loss: does application of glucocorticoids make sense? Arch Otolaryngol Head Neck Surg 2001;127(3):253-8.